"Het Universitair Ziekenhuis Antwerpen is een universitair centrum voor topklinische en klantvriendelijke patiëntenzorg, hoogwaardige academische opleiding en grensverleggend wetenschappelijk onderzoek met een belangrijke internationale dimensie. Gespecialiseerde artsen en zorgverleners omringen elke patiënt met een persoonlijke aanpak en innovatieve technieken en behandelingen."

During the past decade, Universitair Ziekenhuis Antwerpen, Gastro-Enterologie, conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitair Ziekenhuis Antwerpen, Gastro-Enterologie," are "Diabetes Mellitus" (3 trials) and "Gastroparesis" (3 trials). Many other conditions were trialed in "Universitair Ziekenhuis Antwerpen, Gastro-Enterologie," in a lesser frequency.

Most popular intervention types in "Universitair Ziekenhuis Antwerpen, Gastro-Enterologie," are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials) and "Relamorelin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Universitair Ziekenhuis Antwerpen, Gastro-Enterologie," are 3 trials for "All" genders.

Currently, there are NaN active trials in "Universitair Ziekenhuis Antwerpen, Gastro-Enterologie,". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Universitair Ziekenhuis Antwerpen, Gastro-Enterologie,, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Universitair Ziekenhuis Antwerpen, Gastro-Enterologie,, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".